RICCI, R.P., G.L. BOTTO, J.M. BENEZET, J.C. NIELSEN, L. DE ROY, O. PIOT, A. QUESADA, R. QUAGLIONE, D. VACCARI, L. MANGONI, A. GRAMMATICO a Milan KOZÁK. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study. Heart Rhythm. USA: Elsevier Science, 2015, roč. 12, č. 11, s. 2239-2246. ISSN 1547-5271. Dostupné z: https://dx.doi.org/10.1016/j.hrthm.2015.06.041.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study
Autoři RICCI, R.P. (380 Itálie), G.L. BOTTO (380 Itálie), J.M. BENEZET (724 Španělsko), J.C. NIELSEN (208 Dánsko), L. DE ROY (56 Belgie), O. PIOT (250 Francie), A. QUESADA (724 Španělsko), R. QUAGLIONE (380 Itálie), D. VACCARI (380 Itálie), L. MANGONI (380 Itálie), A. GRAMMATICO (380 Itálie) a Milan KOZÁK (203 Česká republika, domácí).
Vydání Heart Rhythm, USA, Elsevier Science, 2015, 1547-5271.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 4.391
Kód RIV RIV/00216224:14110/15:00086546
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.hrthm.2015.06.041
UT WoS 000366112600009
Klíčová slova anglicky Cardiac pacing; Managed ventricular pacing; Randomized controlled trial; Atrial fibrillation; PR interval
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 11. 2. 2016 14:19.
Anotace
BACKGROUND Pacing in the right ventricle can cause a variety of detrimental effects, including atrial tachyarrhythmias (atrial tachycardia [AT]/atrial fibrillation [AF]). OBJECTIVE The purpose of this study was to evaluate the incidence and predictors of persistent AT/AF in patients with long-term exposure to ventricular pacing. METHODS In a multicenter international trial, 605 patients (age 75 +/- 11 years, 240 women) referred for replacement of an implanted pacemaker or implantable cardioverter-defibrillator (ICD), with a history of high-percentage (>40%) ventricular pacing, were randomly allocated to standard dual-chamber pacing or managed ventricular pacing (MVP), a pacing modality that minimizes ventricular pacing. The main end-point of this secondary analysis of the PreFER MVP randomized study was persistent AT/AF, defined as >= 7 consecutive days with AT/AF or AT/AF interrupted by atrial cardioversion or AT/AF present during 2 consecutive follow-up visits. RESULTS Persistent AT/AF was observed in 71 patients (11.7%) after 2 years of follow-up. At multivariable Cox regression analysis, prior AT/AF (hazard ratio [HR] 2.85, 95% confidence interval [CI] 1.20-6.22, P = .017) and ventricular pacing percentage, estimated in the first 3 months, >= 10% (HR 3.24, 95%95% CI 1.13-9.31, P = .029) were independent predictors for persistent AT/AF. MVP was associated with persistent AT/AF risk (HR 3.41, 95% 95% CI 1.10-10.6, P = .024) in the subgroup of patients with baseline long PR interval (PR >230 ms) but not in the whole population. CONCLUSION In pacemaker and ICD replacement patients, a high percentage of ventricular pacing is associated with higher risk of persistent AT/AF. Use of algorithms that minimize right ventricular pacing may benefit patients with normal spontaneous AV conduction but should be evaluated with caution in patients with long PR interval.
VytisknoutZobrazeno: 20. 9. 2024 15:38